Papers
3
Total Citations
62
H-Index
3
About
Dr. Sergio Gentilli is a leading colorectal surgeon whose research focuses on optimizing surgical outcomes for patients with colorectal cancer, particularly through the application of minimally invasive techniques. His work is distinguished by a strong emphasis on evidence-based practice, especially regarding the timing of surgery after chemoradiotherapy and the benefits of robotic and laparoscopic approaches. Dr. Gentilli’s major contributions include the TiMiSNAR trial (cited 14 times), a landmark multicenter randomized controlled trial investigating whether a longer interval (12 weeks) between neoadjuvant chemoradiotherapy and surgery improves outcomes compared to the standard 8 weeks—a question of critical importance in rectal cancer management. He has also advanced the field by demonstrating the safety and efficacy of robotic colorectal surgery in elderly patients (35 citations), a rapidly growing demographic. Furthermore, his collaborative multicenter study on segmental transverse colectomy (13 citations) provides crucial evidence supporting the advantages of minimally invasive surgery for this technically challenging tumor location. Through these impactful studies, Dr. Gentilli is shaping modern colorectal surgical practice, balancing oncologic rigor with patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3